FibroBiologics, Inc. - Common Stock (FBLG) Beats Q2 Earnings Estimates by $0.27
Earnings Results FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly earnings results on July 31, 2026 that exceeded analyst expectations. The Healthcare company…
Read more
